aminocaproic acid

Aminopronova kislota

Instructions for medical use

Active substance: aminocapronic acid; 1 tablet contains 500 mg of aminocaproic acid. Excipients: colloidal anhydrous silica, povidone (polyvinylpyrrolidone), croscarmellose sodium, magnesium stearate.

Форма випуску:
Tablets. 10 tablets in a blister, 2 blisters in a pack or 20 tablets in a container.

Cessation and prevention of bleeding caused by high blood fibrinolytic activity and state of hypo- and afibrinogenemia. Surgical intervention on the organs rich in fibrinolysis activators (lungs, brain, uterus, prostate, pancreas, thyroid, adrenal glands), with burn disease, complications of abortion, uterine bleeding, with internal diseases accompanied by hemorrhagic syndrome, liver diseases, acute pancreatitis, cholecystopancreatitis, pernicious and hypoplastic anemia, leukemia, allergic diseases (allergic rhinitis, chronic tonsillitis, rhinopathy, skin vasculitis, asthma).

Схема прийому:
Aminocaproic acid tablets for oral administration. Depending on the blood coagulation system of adults appoint 1-10 tablets per reception 4-5 times a day.
For 11-18 years old - single - 3-5 grams (6-10 tablets) daily - 18-30 g (36-60 tablets).
Children under 3 years of drug product prescribed with another dosage form.